首页> 外文期刊>Annals of King Edward Medical University. >Clinical Application of Grace Risk Score in Patients with Acute Coronary Syndrome
【24h】

Clinical Application of Grace Risk Score in Patients with Acute Coronary Syndrome

机译:急性冠脉综合征患者恩典风险评分的临床应用

获取原文
           

摘要

Objectives: To determine clinical application of GRACE risk score in patients with acute coronary syndrome (ACS).Patients and Methods: It was an observational analytical study conducted in the Cardiology ward of Mayo hospital, Lahore from April to July 2015. Patients with Acute STEMI, NSTEMI or Unstable angina (UA) were selected on the basis of typical chest pain, ECG changes or cardiac biomarkers .For all eligible cases, at presentation GRS was calculated using online calculator. Also, GRACE risk categories and predicted in-hospital mortality were determined. Patients with previous episodes of STEMI/ NSTEMI, old Left Bundle Branch Block (LBBB), stable angina pectoris, acute pericarditis, myocarditis, acute rheumatic fever or pulmonary embolism were excluded. Data was analyzed on SPSS 20 and the R project for statistical computing. Individual components of GRS were compared among discharged and expired cases using t-test. A p-value of <0.05 was considered significant.Results: A total of 165 patients with STEMI and ACS were included. The mean GRS among males andfemales was 137.4 ± 39 and 151.5 ± 50.6. The observed in-hospital mortality was 12.12% with 60% patients of STEMI. Among expired cases, 90% patients had high GRS, predominantly from STEMI group. Important determinants of adverse outcome were advanced age, tachycardia, low systolic blood pressure and presence of cardiac failure.Conclusion: STEMI was the major acute cardiac event. The mean GRS of expired patients was significantly higher than discharged group. GRS accurately identified low risk cases with low probability of in-hospital death. GRS over estimate probability of in-hospital death among STEMI high risk cases that had higher scores and discharged uneventfully. Grace Risk Score is a reliable predictor of risk category and adverse outcomes and its use by clinicians should be strongly recommended.
机译:目的:确定GRACE危险评分在急性冠脉综合征(ACS)患者中的临床应用。患者和方法:这是一项观察性分析研究,于2015年4月至7月在拉合尔市梅奥医院的心脏病学病房中进行。急性STEMI患者根据典型的胸痛,ECG改变或心脏生物标志物选择NSTEMI或不稳定型心绞痛(UA)。对于所有符合条件的病例,在报告时,GRS使用在线计算器计算。此外,确定了GRACE风险类别和预计的院内死亡率。排除先前有STEMI / NSTEMI发作,旧的左束支传导阻滞(LBBB),稳定的心绞痛,急性心包炎,心肌炎,急性风湿热或肺栓塞的患者。在SPSS 20和R项目上分析数据以进行统计计算。使用t检验比较出院和死亡病例中GRS的各个组成部分。 p值<0.05被认为具有显着性。结果:纳入165例STEMI和ACS患者。男性和女性的平均GRS分别为137.4±39和151.5±50.6。 60%STEMI患者的住院死亡率为12.12%。在过期病例中,有90%的患者GRS高,主要来自STEMI组。不良后果的重要决定因素是高龄,心动过速,收缩压低和心力衰竭的存在。结论:STEMI是主要的急性心脏事件。死亡患者的平均GRS显着高于出院组。 GRS准确地识别出院内死亡可能性低的低风险病例。 GRS高估了得分较高且出院不均的STEMI高危病例中院内死亡的可能性。宽限度风险评分是风险类别和不良后果的可靠预测指标,应强烈建议临床医生使用该评分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号